Stay updated on Pembrolizumab in Advanced Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Gastric Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Gastric Cancer Clinical Trial page
- Check6 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.0%
- Check13 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check20 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an opportunity for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.7%
- Check27 days agoNo Change Detected
- Check49 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
- Check63 days agoChange DetectedThe web page has been updated to reflect a new version of a clinical trial study for gastric adenocarcinoma, including changes in the study's design and identifiers, while removing detailed descriptions of treatment arms and efficacy hypotheses.SummaryDifference17%
- Check70 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
Stay in the know with updates to Pembrolizumab in Advanced Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Gastric Cancer Clinical Trial page.